Hólyagrák: vizsgálatok itt: Hollandia
33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00 - 3. fázisTaking peopleA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Where
- Amsterdam, Maastricht, Nieuwegein, Nijmegen, Rotterdam, Tilburg, Zwolle
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07419295 · EU 2024-520014-22-00 - 1. fázisTaking peopleFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Where
- GE Rotterdam
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05614739 · EU 2022-502755-59-00 - 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Where
- Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06919965 · EU 2024-519493-39-00 - 2/3. fázisTaking peopleDato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Amsterdam, Maastricht, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 · EU 2024-516906-47-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2. fázisTaking peoplePerioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06960577 · EU 2024-519246-75-01 - 3. fázisTaking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Amsterdam, Breda, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00 - 2. fázisNot yet taking people in HollandiaA study investigating whether it is possible to preserve the bladder in participants with bladder cancer by starting with the drugs enfortumab vedotin plus pembrolizumab, followed by further treatment of the bladder depending on the effect on the bladder tumor: FIDELIO
- Where
- Amsterdam, Leiden, Utrecht
- Életkor
- 18 év and over
- People
- 56
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2026-525965-29-00 · EU 2026-525965-29-00 - 2. fázisNot yet taking people in HollandiaFeasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma
- Where
- Amsterdam, Leiden, Nijmegen
- Életkor
- 18 év and over
- People
- 196 worldwide
- Run by
- European Uro-Oncology Group Stichting
See details and how to joinNCT02969083 · EU 2024-514991-41-01 - 1/2. fázisTaking peopleKEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07232602 · EU 2025-522253-19-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Arnhem, Rotterdam
- Életkor
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - No phaseTaking peopleProspective Bladder Cancer Infrastructure (ProBCI)
- Where
- Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede, Emmen, Groningen, Hoofddorp, Leeuwarden, Leiderdorp, Maastricht, Nijmegen, Rotterdam, 's-Hertogenbosch, Sittard, Tilburg, Utrecht, Venlo, Winterswijk, Zwolle
- Életkor
- 18 év and over
- People
- 3600
- Run by
- Prospective Bladder Cancer Infrastructure Foundation
See details and how to joinNCT04503577 - 1/2. fázisTaking peopleLow-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06668493 · EU 2024-514360-70-00 - 1. fázisTaking peoplePHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS WITH MUSCLE INVASIVE BLADDER CANCER (MIBC) OR LOCALIZED OR LOCALLY ADVANCED RENAL CELL CANCER (RCC).
- Where
- Amsterdam, Leiden, Rotterdam
- Életkor
- 18 év and over
- People
- 83
- Run by
- CimCure B.V.
See details and how to join2025-523781-25-00 · EU 2025-523781-25-00 - 1. fázisTaking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - 1. fázisTaking peopleFirst-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644755 - No phaseTaking peopleIrreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 27
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT07782164 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Amsterdam, Breda, Leeuwarden
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Rotterdam
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1/2. fázisTaking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Amsterdam, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - 2. fázisNot yet taking people in HollandiaEnfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC
- Where
- Amsterdam, Leiden, Utrecht
- Életkor
- 18 év and over
- People
- 56
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07663747 - 1. fázisTaking peopleA Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen
- Életkor
- 18 év and over
- People
- 21
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-516870-31-00 · EU 2024-516870-31-00 - 4. fázisNot yet taking people in HollandiaAvelumab Short Maintenance Trial
- Where
- Alkmaar, Amsterdam, Arnhem, Breda, Deventer, Eindhoven, Enschede, Heerlen, Hoofddorp, Leiden, Nieuwegein, Nijmegen, Rotterdam, 's-Gravenhage, Tilburg, Zwolle
- Életkor
- 18 év and over
- People
- 121
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-512975-11-01 · EU 2024-512975-11-01